GI Oncology
News
Brivanib Can't Match Sorafenib for Advanced Liver Cancer
Major Finding: Comparisons of the median overall survival between brivanib- and sorafenib-treated patients showed an overall hazard ratio of 1.07...
News
Earlier End-of-Life Talks Deter Aggressive Care of Terminal Cancer Patients
Major Finding: Chemotherapy in the last 2 weeks of life was 59% less likely, acute care in the last 30 days was 57% less likely, and ICU care in...
News
Antivirals Linked to Lower Risk of Liver Cancer Return
Major Finding: The cumulative 6-year rate of hepatocellular carcinoma recurrence was 45.6% for patients taking nucleoside analogues and 54.6% for...
News
Management of Zollinger-Ellison May Depend on Presence of Tumors
News
Evidence Mounts for Continuing Bevacizumab After Colorectal Cancer Progresses
Major Finding: Median progression-free survival was 4.9 months with second-line chemotherapy alone vs. 6.7 months with the addition of bevacizumab...
News
Less Liver Cancer in HCV Patients Given Antiviral Therapy
Major Finding: Antiviral therapy for hepatitis C carried a relative risk of 0.53 for developing hepatocellular carcinoma, compared with no...
News
Gefitinib Offers Palliative Care in Advanced Esophageal Cancer
Major Finding: Median overall survival was 3.73 months with gefitinib vs. 3.60 months with placebo (P = .285).Data Source: Data are from a phase...
News
FDA Approves Regorafenib for Metastatic Colorectal Cancer
News
Long-Term Follow-Up Warranted After Gastric MALT Lymphoma Remission
Major Finding: Of 120 participants, 96 (80%) achieved complete remission of gastric MALT lymphoma, and 80% of them (77/96) remained disease free....
News
Ablation Cost Effective for High-Grade Dysplasia in Barrett's Esophagus
News
Robotic Device for Gastric Neoplasia Found Safe in Five Patients
Major Finding: Five patients who underwent endoscopic submucosal dissection of early-stage gastric neoplasia with the use of a novel robotic...